Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Acta Pharmaceutica Sinica B is Scopus-indexed (Q1, CiteScore 24.4), WoS SCIE, DOAJ. It is covered by India's One Nation One Subscription scheme, which pays the article processing charge for authors at eligible institutions. Published by Chinese Academy of Medical Sciences.
Checked against the index lists dated .
ISSN 2211-3835Verify ISSN ↗2211-3843Verify ISSN ↗
Publisher: Chinese Academy of Medical Sciences
Cost to publish: APC covered for authors at ONOS-subscribed Indian institutions
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology, Toxicology and Pharmaceutics (all) | 1 / 79 | 99th | Q1 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription)
Yes — actively indexed in Scopus, coverage 2012–present, best quartile Q1, CiteScore 24.4.
Acta Pharmaceutica Sinica B is Q1 in Pharmacology, Toxicology and Pharmaceutics (all) (rank 1 of 79), by CiteScore 2025.
Acta Pharmaceutica Sinica B is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 24.4, which places it in quartile Q1 at the 99th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 3.439, quartile Q1, with an H-index of 146.
For authors at Indian institutions covered by One Nation One Subscription (ONOS), the article processing charge is paid by the scheme. The publisher lists an article processing charge of about US$2,600 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Acta Pharmaceutica Sinica B is published by Chinese Academy of Medical Sciences. Its print ISSN is 2211-3835 and its online ISSN is 2211-3843.
Yes. ONOS also covers its article processing charge for authors at eligible institutions.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Acta Pharmaceutica Sinica B has an h-index of 168 and a 2-year mean of 9.98 citations per paper (OpenAlex). Its Scopus CiteScore is 24.4, quartile Q1. On 2-year citations it ranks #2 of 77 Scopus journals in Pharmacology, Toxicology and Pharmaceutics (all).
Acta Pharmaceutica Sinica B published 501 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 81 research articles (2026), authors are most often from China (71.4%), United States (7.1%) and Singapore (2.8%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 5 retracted papers are recorded (1.5 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.